We are live on ! Find out more
ANGO icon

AngioDynamics

91 hedge funds and large institutions have $305M invested in AngioDynamics in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more call options, than puts

Call options by funds: $50K | Put options by funds: $17K

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

14% more capital invested

Capital invested by funds: $268M → $305M (+$36.6M)

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

8% more funds holding

Funds holding: 8491 (+7)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
91
Holders Change
+7
Holders Change %
+8.33%
% of All Funds
2.94%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
13
Increased
34
Reduced
30
Closed
6
Calls
$50K
Puts
$17K
Net Calls
+$33K
Net Calls Change
+$93K

ANGO Hedge Fund Activity: Q3 2013 in Review

91 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2013, worth a combined $305M — up 14% from $268M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ANGO positions and 6 closed out — a net gain of 7 holders — while 34 added to existing stakes and 30 trimmed.

The largest buyer was RGM Capital, adding an estimated $3.78M. The largest seller was Perkins Investment Management, exiting entirely with an estimated $10.5M sold.

  • 91 institutional investors held AngioDynamics (ANGO) as of Q3 2013, up from 84 in Q2 2013.
  • Funds reported $305M of AngioDynamics stock for Q3 2013, up 14% quarter-over-quarter.
  • 13 funds opened new AngioDynamics positions in Q3 2013 and 6 closed out, a net change of +7 holders.
  • The largest AngioDynamics buyer in Q3 2013 was RGM Capital, an estimated $3.78M added.
  • The largest AngioDynamics seller in Q3 2013 was Perkins Investment Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q3 2013.